Jeffrey Dierks - 04 Oct 2023 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol
HRMY
Transactions as of
04 Oct 2023
Net transactions value
$0
Form type
4
Filing time
08 Nov 2023, 16:02:09 UTC
Previous filing
04 Oct 2022
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Restricted Stock Units Award $0 +150,000 $0.000000 150,000 04 Oct 2023 Common Stock 150,000 $31.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.